RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia. (Q52002743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

P Gaynon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

L L Robison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

J P Perentesis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

S Bhatia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

E Boyle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Y Shao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

M Steinbuch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

H N Sather

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

W Kiffmeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

J Envall-Fox

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

685-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990973%20AND%20SRC:MED&resulttype=core&format=json

RAS and leukemia: from basic mechanisms to gene-directed therapy

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

ras oncogenes: their role in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Residential exposure to magnetic fields and acute lymphoblastic leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Analysis of RAS oncogene mutations in human lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Targeted therapies for high-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

Parental cigarette smoking and the risk of acute leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021

Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021

Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021

Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403272

7 January 2021